Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 11/20 | 0.43 |
| ▸ | BRD4 | O60885 | 11/20 | 0.43 |
| ▸ | PTK2 | Q05397 | 3/20 | 0.42 |
| ▸ | CDK4 | P11802 | 3/20 | 0.42 |
| ▸ | CCND1 | P24385 | 1/20 | 0.42 |
| ▸ | CCND2 | P30279 | 1/20 | 0.42 |
| ▸ | CCND3 | P30281 | 1/20 | 0.42 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.42 |
| ▸ | STAT6 | P42226 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27915943 | 0.92 | JAK2 (0.51) | JAK2BRD4PTK2CDK4RPS6KA3 | |
| SCHEMBL1654994 | 0.85 | BRD4 (0.55) | JAK2BRD4PTK2CDK4CCND1 | |
| SCHEMBL4290087 | 0.85 | JAK2 (0.53) | JAK2BRD4PTK2CDK4CCND1 | |
| SCHEMBL27916064 | 0.84 | JAK2 (0.53) | JAK2BRD4CDK4RPS6KA3AURKA | |
| SCHEMBL27934423 | 0.83 | JAK2 (0.55) | JAK2BRD4PTK2CDK4RPS6KA3 | |
| SCHEMBL27934450 | 0.81 | PTK2 (0.48) | JAK2BRD4PTK2RPS6KA3AURKA | |
| SCHEMBL27934454 | 0.79 | WEE1 (0.46) | JAK2BRD4CDK4CCND1CCND2 | |
| SCHEMBL27915897 | 0.79 | JAK2 (0.57) | JAK2BRD4PTK2CDK4RPS6KA3 | |
| SCHEMBL27934426 | 0.78 | JAK2 (0.51) | JAK2BRD4PTK2CDK4RPS6KA3 | |
| SCHEMBL1655850 | 0.77 | BRD4 (0.65) | JAK2BRD4CDK4RPS6KA3AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101981036-B | Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors | NOVARTIS AG | 2013-09-04 | — | — | CN | disclosed |